Thymomas are fascinating tumors because of their multifaceted clinical pres
entation, including an unrivaled frequency of associated paraneoplastic aut
oimmune diseases and an astounding histologic heterogeneity. Thus, thymomas
challenge the clinician, pathologist, and immunologist alike with complex
diagnostic and therapeutic problems in almost all fields of medicine, radio
logy, nuclear medicine, surgery, radiooncology, and pathology. This review
highlights recent progress in these fields, including the new World Health
Organization's classification of thymomas, and reports on the beginning dis
covery of the genetic basis of thymoma oncogenesis and the cellular and mol
ecular immunopathology of thymoma-associated paraneoplastic autoimmunity. C
urr Opin Oncol 2000, 12:426-433 (C) 2000 Lippincott Williams & Wilkins, Inc
.